Table 2 Patient and treatment characteristics
Variable | N° (%) |
|---|---|
Age | |
 Mean | 65 |
 Rage | 50–78 |
Sex | |
 Female | 5 (50%) |
 Male | 5 (50%) |
T stage | |
 T2 | 5 (50%) |
 T3 | 5 (50%) |
N stage | |
 N0–1 | 2 (20%) |
 N2 | 6 (60%) |
 N3 | 2 (20%) |
Global stage | |
 II | 2 (20%) |
 IIIB | 8 (80%) |
PTV dose-tumor (Gy) | |
 54 Gy | 10 (100%) |
PTV dose-positive nodes (Gy) | |
 54 Gy | 2 (20%) |
 50.4 Gy | 5 (50%) |
PTV dose-elective volumes (Gy) | |
 45 Gy | 10 (10%) |